Journal article

What is responsible for the recent improvements in outlook for patients with follicular lymphoma?

Mark J Bishton, John F Seymour

LEUKEMIA & LYMPHOMA | TAYLOR & FRANCIS LTD | Published : 2010

DOI: 10.3109/10428194.2010.493252

University of Melbourne Researchers

Keywords

Science & Technology
Indolent
Survival
Therapy
Cell Lymphoma
Rituximab
3201 Cardiovascular Medicine and Haematology
32 Biomedical and Clinical Sciences
Life Sciences & Biomedicine
Oncology
Hematology